Shareholders' Equity

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Shareholders' Equity

Shareholders' Equity

Stock Repurchase Program

The 2024 Repurchase Program authorizes the repurchase of up to 850,000 shares, or approximately 5%, of the Bancorp’s outstanding common stock. This authority may be exercised from time to time and in such amounts as market conditions warrant, and subject to regulatory considerations. The timing and actual numbers of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions, and other corporate liquidity requirements and priorities. The 2024 Repurchase Program commenced on January 1, 2024 and expires on December 31, 2024, and may be modified, suspended, or discontinued at any time. As of September 30, 2024, no shares have been repurchased under the 2024 Repurchase Program.

Regulatory Capital Requirements

Capital levels at September 30, 2024 exceeded the regulatory minimum levels to be considered “well capitalized.”

The following table presents the Corporation’s and the Bank’s actual capital amounts and ratios, as well as the corresponding minimum and well capitalized regulatory amounts and ratios that were in effect during the respective periods:

(Dollars in thousands)	Actual			For Capital Adequacy Purposes			To Be “Well Capitalized” Under Prompt Corrective Action Provisions
	Amount	Ratio		Amount	Ratio		Amount	Ratio
September 30, 2024
Total Capital (to Risk-Weighted Assets):
Corporation	$618,974	12.21	%	$405,397	8.00	%	N/A	N/A
Bank	612,980	12.10		405,250	8.00		$506,562	10.00	%
Tier 1 Capital (to Risk-Weighted Assets):
Corporation	577,073	11.39		304,048	6.00		N/A	N/A
Bank	571,079	11.27		303,937	6.00		405,250	8.00
Common Equity Tier 1 Capital (to Risk-Weighted Assets):
Corporation	555,077	10.95		228,036	4.50		N/A	N/A
Bank	571,079	11.27		227,953	4.50		329,265	6.50
Tier 1 Capital (to Average Assets): (1)
Corporation	577,073	7.85		293,972	4.00		N/A	N/A
Bank	571,079	7.77		293,870	4.00		367,338	5.00
December 31, 2023
Total Capital (to Risk-Weighted Assets):
Corporation	611,220	11.58		422,259	8.00		N/A	N/A
Bank	605,289	11.47		422,131	8.00		527,663	10.00
Tier 1 Capital (to Risk-Weighted Assets):
Corporation	572,960	10.86		316,694	6.00		N/A	N/A
Bank	567,029	10.75		316,598	6.00		422,131	8.00
Common Equity Tier 1 Capital (to Risk-Weighted Assets):
Corporation	550,964	10.44		237,521	4.50		N/A	N/A
Bank	567,029	10.75		237,449	4.50		342,981	6.50
Tier 1 Capital (to Average Assets): (1)
Corporation	572,960	7.80		293,837	4.00		N/A	N/A
Bank	567,029	7.72		293,742	4.00		367,177	5.00

(1)    Leverage ratio.

In addition to the minimum regulatory capital required for capital adequacy outlined in the table above, the Corporation and the Bank are required to maintain a minimum capital conservation buffer, in the form of common equity, of 2.50%, resulting in a requirement for the Corporation and the Bank to effectively maintain total capital, Tier 1 capital, and common equity Tier 1 capital ratios of 10.50%, 8.50%, and 7.00%, respectively. The Corporation and the Bank must maintain the capital conservation buffer to avoid restrictions on the ability to pay dividends and discretionary bonuses. The Corporation’s and the Bank’s capital levels exceeded the minimum regulatory capital requirements plus the capital conservation buffer at September 30, 2024 and December 31, 2023.

The Bancorp owns the common stock of two capital trusts, which have issued trust preferred securities. In accordance with GAAP, the capital trusts are treated as unconsolidated subsidiaries. At both September 30, 2024 and December 31, 2023, $22.0 million in trust preferred securities were included in the Tier 1 capital of the Corporation for regulatory capital reporting purposes pursuant to the capital adequacy guidelines of the Federal Reserve.

In accordance with regulatory capital rules, the Corporation elected the option to delay the estimated impact of ASC 326 on its regulatory capital over a two-year deferral and subsequent three-year transition period ending December 31, 2024. As a

result, capital ratios exclude the full impact of the increased ACL on loans and unfunded loan commitments attributed to the adoption of ASC 326, adjusted for an approximation of the after-tax provision for credit losses attributable to ASC 326 relative to the incurred loss methodology during the two-year deferral period. The cumulative difference at the end of the deferral period is being phased-in to regulatory capital over the three-year transition period, which began January 1, 2022.